Vancomycin elimination in patients with burn injury
- PMID: 3709027
- DOI: 10.1038/clpt.1986.111
Vancomycin elimination in patients with burn injury
Abstract
Patients with burns clinically appear to require considerably larger doses of vancomycin than normal to attain therapeutic serum concentrations. It has been presumed that this phenomenon is a result of increased renal elimination of this drug consequent to increased glomerular filtration rates in such patients, as has been documented with aminoglycoside antibiotics. We measured the serum clearance of vancomycin in 10 patients with burns and found this parameter to correlate closely with creatinine clearance (serum clearance = 12.5 + 0.695 creatinine clearance; r = 0.932; P less than 0.001). The slope of this relationship was similar to that reported by other investigators in patients not suffering from thermal injury. We conclude that at all levels of renal function, patients with burns clear vancomycin in a manner similar to that of other patients. Consequently, renal function can be used to select a dosing regimen for vancomycin in such patients.
Similar articles
-
Altered vancomycin dose vs. serum concentration relationship in burn patients.Clin Pharmacol Ther. 1988 Jul;44(1):9-13. doi: 10.1038/clpt.1988.105. Clin Pharmacol Ther. 1988. PMID: 3292106 Clinical Trial.
-
Vancomycin pharmacokinetics in critically ill patients.J Antimicrob Chemother. 1984 Dec;14 Suppl D:53-7. doi: 10.1093/jac/14.suppl_d.53. J Antimicrob Chemother. 1984. PMID: 6520066
-
Vancomycin disposition: the importance of age.Clin Pharmacol Ther. 1984 Dec;36(6):803-10. doi: 10.1038/clpt.1984.260. Clin Pharmacol Ther. 1984. PMID: 6499360
-
Pharmacokinetics of systemically administered antibiotics in patients with thermal injury.Clin Infect Dis. 1992 Feb;14(2):458-63. doi: 10.1093/clinids/14.2.458. Clin Infect Dis. 1992. PMID: 1554831 Review.
-
Clinical pharmacokinetics of vancomycin.Clin Pharmacokinet. 1986 Jul-Aug;11(4):257-82. doi: 10.2165/00003088-198611040-00001. Clin Pharmacokinet. 1986. PMID: 3530582 Review.
Cited by
-
Antimicrobial therapy in critically ill patients: a review of pathophysiological conditions responsible for altered disposition and pharmacokinetic variability.Clin Pharmacokinet. 2005;44(10):1009-34. doi: 10.2165/00003088-200544100-00002. Clin Pharmacokinet. 2005. PMID: 16176116 Review.
-
Influence of burns on pharmacokinetics and pharmacodynamics of drugs used in the care of burn patients.Clin Pharmacokinet. 2008;47(10):635-54. doi: 10.2165/00003088-200847100-00002. Clin Pharmacokinet. 2008. PMID: 18783295 Review.
-
Pharmacokinetics of cefepime in patients with thermal burn injury.Antimicrob Agents Chemother. 1999 Dec;43(12):2848-54. doi: 10.1128/AAC.43.12.2848. Antimicrob Agents Chemother. 1999. PMID: 10582870 Free PMC article. Clinical Trial.
-
Initial vancomycin dosing recommendations for critically ill patients undergoing continuous venovenous hemodialysis.Can J Hosp Pharm. 2010 May;63(3):196-206. doi: 10.4212/cjhp.v63i3.915. Can J Hosp Pharm. 2010. PMID: 22478979 Free PMC article.
-
Vancomycin pharmacokinetics in burn patients and intravenous drug abusers.Antimicrob Agents Chemother. 1990 May;34(5):792-5. doi: 10.1128/AAC.34.5.792. Antimicrob Agents Chemother. 1990. PMID: 2360818 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical